Debt Financings

ZIMMER BIOMET HOLDINGS, INC. incurred senior notes of $600,000,000 with noteholders at 5.500% maturing February 19, 2035.

“On February 19, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) completed its previously announced issuance of $600,000,000 aggregate principal amount of its 4.700% notes due 2027 (the “2027 Notes”), $550,000,000 aggregate principal amount of its 5.050% notes due 2030 (the “2030 Notes”) and $600,000,000 aggregate principal amount of its 5.500% notes due 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2030 Notes, the “Notes”).”

ZIMMER BIOMET HOLDINGS, INC. incurred senior notes of $550,000,000 with noteholders at 5.050% maturing February 19, 2030.

“On February 19, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) completed its previously announced issuance of $600,000,000 aggregate principal amount of its 4.700% notes due 2027 (the “2027 Notes”), $550,000,000 aggregate principal amount of its 5.050% notes due 2030 (the “2030 Notes”) and $600,000,000 aggregate principal amount of its 5.500% notes due 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2030 Notes, the “Notes”).”

ZIMMER BIOMET HOLDINGS, INC. incurred senior notes of $600,000,000 with noteholders at 4.700% maturing February 19, 2027.

“On February 19, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) completed its previously announced issuance of $600,000,000 aggregate principal amount of its 4.700% notes due 2027 (the “2027 Notes”), $550,000,000 aggregate principal amount of its 5.050% notes due 2030 (the “2030 Notes”) and $600,000,000 aggregate principal amount of its 5.500% notes due 2035 (the “2035 Notes” and, together with the 2027 Notes and the 2030 Notes, the “Notes”).”

Bespoke Extracts, Inc. incurred loan of $169,000 with WL Holdings, LTD at 10% per annum maturing December 31, 2030.

“pursuant to the Agreement described in Item 1.01 above, Bespoke Colorado issued a promissory note (the “Note”) to WL Holdings, LTD in the principal amount of $169,000”

Sila Realty Trust, Inc. amended term loan of Not restated; aggregate commitments across three facilities $1,125,000,000 with Truist Bank at Not restated in excerpt maturing Not restated in excerpt.

“2029 Revolving Credit Agreement, 2027 A&R Term Loan Agreement, and 2028 Term Loan Agreement are pari passu, and, collectively, have current aggregate commitments available of $1,125,000,000. Borrowings under the 2029 Revolving Credit Agreement are guaranteed by SROP, and certain subsidiaries of the Company. The material terms of the 2029 Revolving Credit Agreement,”

Sila Realty Trust, Inc. incurred revolving credit of up to $600,000,000, which may be increased to up to $1,500,000,000 with Bank of America, N.A. at Base Rate plus margin of 0.25% to 0.90% or SOFR plus margin of 1.25% to 1.90% maturing February 16, 2029.

“On February 18, 2025, Sila Realty Trust, Inc. (the “Company”), Sila Realty Operating Partnership, LP (“SROP”), and certain of the Company’s subsidiaries, entered into a senior unsecured revolving credit agreement (“2029 Revolving Credit Agreement”) with Bank of America, N.A., as Administrative Agent, for aggregate commitments available of up to $600,000,000, which may be increased, subject to lender approval, to an aggregate amount not to exceed $1,500,000,000.”

Odyssey Health, Inc. amended convertible notes with LGH Investments, LLC maturing July 31, 2025.

“On February 19, 2025, effective December 31, 2024, the Company entered into Amendment No. 9 to the Convertible Promissory Note to the Securities Purchase Agreement dated April 5, 2021, with LGH Investments, LLC. Pursuant to the Amendment No. 9, the parties have agreed to extend the maturity date of the note to July 31, 2025.”

Odyssey Health, Inc. amended loan with Jon Lutz maturing July 31, 2025.

“On February 13, 2025, the Company entered into Amendment No. 3 to the Promissory Note; dated February 13, 2024 with Jon Lutz, an accredited investor. Pursuant to the Amendment No 3, the parties have agreed to extend the maturity date of the note to July 31, 2025.”

Nikola Corp faced acceleration on convertible notes of $12,394,656 in aggregate principal amount of the June 2023 Notes with U.S. Bank Trust Company, National Association at 8.00% / 8.00% maturing due 2026.

“On the Filing Date, (i) the aggregate principal amount of the Debt Instruments and (ii) accrued and unpaid interest thereon to the Filing Date, in each case, immediately became due and payable by the Company in the amounts set forth below on the Filing Date without declaration, notice or other action of the holders thereof or the trustee under the indenture that governs such Debt Instruments in accordance with the terms thereof: • $31,782,344 in aggregate principal amount of the June 2022 Notes and $557,956.71 in accrued and unpaid interest thereon; and • $12,394,656 in aggregate principal amount of the June 2023 Notes and $134,964.03 in accrued and unpaid interest thereon.”

Nikola Corp faced acceleration on convertible notes of $31,782,344 in aggregate principal amount of the June 2022 Notes with U.S. Bank Trust Company, National Association at 8.00% / 11.00% maturing due 2026.

“On the Filing Date, (i) the aggregate principal amount of the Debt Instruments and (ii) accrued and unpaid interest thereon to the Filing Date, in each case, immediately became due and payable by the Company in the amounts set forth below on the Filing Date without declaration, notice or other action of the holders thereof or the trustee under the indenture that governs such Debt Instruments in accordance with the terms thereof: • $31,782,344 in aggregate principal amount of the June 2022 Notes and $557,956.71 in accrued and unpaid interest thereon; and • $12,394,656 in aggregate principal amount of the June 2023 Notes and $134,964.03 in accrued and unpaid interest thereon.”

APi Group Corp incurred term loan of approximately $2,157 million with Citibank, N.A. at a base rate, plus a reduced applicable margin, equal to 0.75% per annum or (2) a maturing January 3, 2029.

“Amendment No. 7 provides for the refinancing of the existing incremental term loans, denominated in U.S. dollars (the “Existing 2021 Incremental Term Loans”), in full by borrowing principal amounts under the Credit Agreement of approximately $2,157 million (the “Repriced 2021 Incremental Term Loans”), to pay off the outstanding incremental term loans maturing January 3, 2029 under the Existing Credit Agreement on the Funding Date.”

TriSalus Life Sciences, Inc. incurred term loan of $10 million with OrbiMed Royalty & Credit Opportunities IV, LP maturing April 30, 2029.

“y ”) and TriSalus Operating Life Sciences, Inc., a Delaware corporation and wholly owned subsidiary of the Company (the “ Borrower ”) entered into a Credit Agreement (the “ Credit Agreement ”), by and between the Company, as parent, the Borrower, as borrower, OrbiMed Royalty & Credit Opportunities IV, LP, a Delaware limited partnership (the “ Initial Lender ”), as a lender, each other lender that may from time to time become a party thereto, and OrbiMed Royalty & Credit Opportunities IV, LP, as administrative agent for the lenders.”

Profusa, Inc. incurred convertible notes of up to $22,222,222 with an institutional investor at 10% per annum maturing 18-months from its respective closing date.

“the conditions relating to such purchase set forth in the SPA, to purchase from NorthView senior secured convertible promissory notes in an aggregate principal amount of up to $22,222,222 (the “Convertible Notes”) for a purchase price of up to $20,000,000, after a 10% original issue discount (“OID”). The SPA contemplates that the Convertible Notes will be purchased”

TWIN DISC INC incurred term loan of Term Loan in the principal amount of $15,000,000 with Bank of Montreal at SOFR, EURIBO Rate, or CORRA plus Applicable Margins between 2.125% and 3.625% fo maturing April 1, 2027.

“that are not otherwise defined herein are defined in the Credit Agreement. Pursuant to the Credit Agreement, the Bank made a Term Loan to the Company in the principal amount of $15,000,000, consisting of as assignment of a term loan under the Prior Credit Agreement from BMO to the Bank with a remaining principal of $8,500,000 and an additional advance of $6,500,000.”

ESSEX PORTFOLIO LP incurred senior notes of $400.0 million with the holders at 5.375% per annum maturing April 1, 2035.

“On February 18, 2025, Essex Portfolio, L.P. (the “Operating Partnership”), the operating partnership of Essex Property Trust, Inc. (the “Company”), issued $400.0 million aggregate principal amount of its 5.375% senior notes due 2035 (the “Notes”).”

PLUS THERAPEUTICS, INC. incurred convertible notes of $3,362,251 with certain existing accredited investors at 10% per annum maturing February 13, 2026.

“On February 13, 2025 (the “Closing Date”), Plus Therapeutics, Inc. (the “Company”) entered into a Securities Purchase and Exchange Agreement (the “SPEA”) with certain existing accredited investors (the “Purchasers”). Pursuant to the SPEA, on the Closing Date the Company issued secured convertible promissory notes (the “Funding Notes”) in the aggregate principal amount of $3,362,251 together with common stock purchase warrants (the “Warrants”) to purchase 3,002,009 shares of the Company common stock, par value $0.001 (the “Common Stock”) at an exercise price of $1.12 per share (the “Warrant Exercise Price”).”

MEDICAL PROPERTIES TRUST INC incurred senior notes of $1,500,000,000 aggregate principal amount (Dollar Notes) and €1,000,000,000 aggregate principal amount (Euro Notes) at 8.500% (Dollar Notes) and 7.000% (Euro Notes) maturing February 15, 2032.

“and €1,000,000,000 aggregate principal amount of the Issuers’ 7.000% Senior Secured Notes due 2032”

FreightCar America, Inc. incurred revolving credit of up to $35.0 million with Bank of America, N.A. at Term SOFR rate plus an applicable margin ranging from 1.50% to 2.00% per annum o maturing February 12, 2030.

“On February 12, 2025, FreightCar America, Inc. (the “Company”), FreightCar North America, LLC (“FCNA”) and certain subsidiaries of FCNA (together with FCNA, collectively, the “Borrowers,” and the Company and the Borrowers, collectively, the “Loan Parties”) entered into a Loan and Security Agreement (the “BofA Loan Agreement”) by and among the Loan Parties, the lenders from time to time party thereto (the “Lenders”), and Bank of America, N.A., as agent for the Lenders (“Agent”). Pursuant to the BofA Loan Agreement, the Lenders extended an asset backed credit facility, in the maximum aggregate principal amount of up to $35.0 million, consisting of revolving loans and a sub-facility for letters of credit.”

Snap Inc amended revolving credit with JPMorgan Chase Bank, N.A., as administrative agent maturing February 12, 2030.

“extends the term of $800.0 million of the Revolving Credit Facility to February 12, 2030, with the remaining $250.0 million of the Revolving Credit Facility maturing on the existing maturity date of May 6, 2027.”

Snap Inc incurred senior notes of $1,500.0 million at 6.875% per year maturing March 1, 2033.

“sale by us of an aggregate of $1,500.0 million principal amount of our 6.875% Senior Notes due 2033”

AB Private Credit Investors Corp amended revolving credit of $250,000,000 with HSBC Bank USA, National Association.

“On February 14, 2025, AB Private Credit Investors Corporation (the “ Fund ”) entered into an amendment (the “ Amendment ”) to the credit agreement establishing its revolving credit facility (the “ Credit Facility ”) with HSBC Bank USA, National Association, as the administrative agent and a lender, and each of the Banks a party thereto. The Amendment, among other changes, made permanent the temporary commitment increases introduced in a prior amendment and, as a result, (i) increased the Credit Facility’s maximum commitment to $250,000,000 and (ii) decreased the Fund’s facility sublimit to $40,000,000.”

HF Foods Group Inc. amended revolving credit of $125,000,000 with JPMorgan Chase Bank, N.A., as administrative agent.

“The Amendment amends certain terms and conditions of the Credit Agreement by, among other things, (i) increasing the Aggregate Revolving Commitment (as defined in the Credit Agreement) from $100,000,000 to $125,000,000, (ii) joining three new subsidiaries of the Company to the Credit Agreement, each as a “Borrower” thereunder, (iii) joining Wells Fargo Bank, N.A. to the Credit Agreement as a “Lender” thereunder, (iv) amending certain affirmative covenants commensurate with the increase in the Aggregate Revolving Commitment, and (v) amending certain restrictions regarding incurring obligations under real property leases and equipment financings in the ordinary course of business.”

Liberty Latin America Ltd. incurred senior notes of $755.0 million aggregate principal amount with The Bank of New York Mellon, London Branch, as trustee and security trustee at 9.000% maturing January 15, 2033.

“The Notes were issued on February 11, 2025 (the “ Issue Date ”) under an indenture, dated the Issue Date (the “ Indenture ”) between, among others, CWSFL and The Bank of New York Mellon, London Branch, as trustee and security trustee. The proceeds from the offering of the Notes are expected to be used to refinance CWSFL’s 6.875% senior notes due 2027, in full, and to pay any related fees, premiums and expenses in connection with the foregoing.”

IMAC Holdings, Inc. incurred loan of aggregate principal amount of $110,000 maturing earlier of (i) November 14, 2025, and (ii) the initial time of consummation by the Company after the date hereof of any public or private offering(s), individua.

“On February 14, 2025, IMAC Holdings, Inc. (the “Company”) issued promissory notes (the “Notes”) to certain lenders (the “Lenders”) in the aggregate principal amount of $110,000, for an aggregate purchase price from the Lenders of $100,000.”

OppFi Inc. amended revolving credit of $300 million with Midtown Madison Management LLC at Term SOFR plus 7.75% maturing February 13, 2029.

“The Second A&R Credit Agreement amended the Existing Credit Agreement to, among other things, increase the size of the facility under the Existing Credit Agreement from $250 million to $300 million and extend the maturity date to February 13, 2029.”

VIP Play, Inc. incurred convertible notes of $210,000 with Excel Family Partners, LLLP at 12.0% maturing April 1, 2025.

“We borrowed an additional $190,000 and $210,000 under the Note on February 3, 2025 and February 12, 2025, respectively.”

VIP Play, Inc. incurred convertible notes of $190,000 with Excel Family Partners, LLLP at 12.0% maturing April 1, 2025.

“We borrowed an additional $190,000 and $210,000 under the Note on February 3, 2025 and February 12, 2025, respectively.”

P3 Health Partners Inc. incurred loan of $30.0 million with VBC Growth SPV 4, LLC at 19.5% per annum maturing August 13, 2028.

“disinterested directors of the Company. VBC 4 Promissory Note The Promissory Note was issued by P3 LLC to VBC 4 on February 13, 2025, and provides for funding of up to $30.0 million (the “Promissory Note”), available for draw by P3 LLC in two tranches, as follows: (i) a first tranche of $15.0 million available to P3 LLC upon the Effective Date, and (ii) a”

Kairous Acquisition Corp. Ltd incurred loan of $50,000 with Kairous Asia Limited maturing matures upon the closing of a business combination by the Company.

“On February 14, 2025, Kairous Acquisition Corp. Limited (the "Company" or "Kairous") issued an unsecured promissory note in the aggregate principal amount of $50,000 (the "Note") to Kairous Asia Limited, the Company’s initial public offering sponsor ("Sponsor") in exchange for Sponsor depositing such amount into the Company’s trust account in order to extend the amount of time it has available to complete a business combination. The Note does not bear interest and matures upon the closing of a business combination by the Company.”

ENvue Medical, Inc. incurred senior notes.

“On February 13, 2025, pursuant to the Purchase Agreement, the Company issued the Debenture to the Investor.”

Guardant Health, Inc. incurred convertible notes of $600 million aggregate principal amount at 1.25% per annum maturing February 15, 2031.

“issued $600 million aggregate principal amount of 1.25% Convertible Senior Notes due 2031”

Super League Enterprise, Inc. incurred loan of $2.5 million with Agile Lending, LLC maturing 32 weeks from the Effective Date.

“On February 10, 2025 (the “Effective Date”), the Company and its subsidiary, InPVP, LLC (“Subsidiary”), entered into a Business Loan and Security Agreement (the “Agile Loan Agreement”), with Agile Capital Funding, LLC as collateral agent (“Collateral Agent”), and Agile Lending, LLC (“Agile”), pursuant to which the Company issued to Agile a Confessed Judgment Secured Promissory Note for an aggregate value of $2.5 million (the “Agile Note”).”

AMERICAN REBEL HOLDINGS INC incurred loan of $155,250 with 1800 Diagonal Lending, LLC at 22% per annum maturing August 15, 2025 and monthly thereafter.

“the Lender made a loan to the Company, evidenced by a promissory note in the principal amount of $155,250”

Ispire Technology Inc. incurred credit facility of up to $20 million with Avon River Ventures LLC at 15.25% maturing February 10, 2027 for the First Tranche.

“On February 10, 2025 (the "Closing Date"), Ispire Technology Inc. (the "Company") entered into a Master Loan and Security Agreement (the "MLSA") with Avon River Ventures LLC (the "Lender" or "Avon"). Pursuant to the MLSA, the Company issued a secured promissory note (the "Promissory Note") in the principal amount of up to $20 million”

EMERSON ELECTRIC CO incurred credit facility of $3 billion with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A. and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein maturing February 10, 2026.

“On February 11, 2025, Emerson Electric Co. (the "Company") entered into a $3 billion 364-Day Credit Agreement (the “364-Day Credit Facility”), dated as of February 11, 2025, with JPMorgan Chase Bank, N.A., as agent, Bank of America, N.A. and Goldman Sachs Bank USA, as syndication agents, and the lenders named therein.”

Sarepta Therapeutics, Inc. incurred revolving credit of $600 million with JPMorgan Chase Bank, N.A. at Adjusted SOFR plus a margin of 1.125% to 1.75% per annum maturing five years from the Closing Date.

“The Credit Agreement provides for a five-year, $600 million senior secured revolving credit facility”

ALEXANDRIA REAL ESTATE EQUITIES, INC. incurred senior notes of $550,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 5.50% per year maturing October 1, 2035.

“On February 13, 2025, Alexandria Real Estate Equities, Inc. (the “Company”) issued and sold $550,000,000 aggregate principal amount of the Company’s 5.50 % Senior Notes due 2035 (the “Notes”) in a registered public offering”

JONES SODA CO. incurred credit facility of up to $5,000,000 with Two Shores Capital Corp. at 13.75% per annum.

“On February 5, 2025, Jones Soda Co. (USA) Inc. (the “Subsidiary”), a wholly-owned subsidiary of Jones Soda Co. (the “Company”) entered into a loan agreement (the “Loan Agreement”) with Two Shores Capital Corp. (the “Lender”), pursuant to which the Subsidiary may borrow a maximum aggregate amount of up to $5,000,000, subject to satisfaction of certain conditions.”

Bally's Corp incurred senior notes of $500.0 million with Alter Domus (US) LLC, as note agent and collateral agent, and the purchasers party thereto at 11.00% maturing October 2, 2028.

“Bally’s, as issuer, and certain of its subsidiaries, as guarntors, entered into a note purchase agreement with Alter Domus (US) LLC, as note agent and collateral agent, and the purchasers party thereto, pursuant to which Bally’s issued $500.0 million of new first lien senior secured notes.”

Vontier Corp incurred revolving credit of $750 million with Bank of America, N.A. at Term SOFR plus a margin of between 1.015% and 1.575%, or Base Rate plus a margin maturing February 12, 2030.

“The Second A&R Credit Agreement consists of a five-year, $750 million senior unsecured, multi-currency revolving credit facility, including a $25 million sublimit for swingline loans and a $75 million sublimit for the issuance of letters of credit (the “Revolving Credit Facility”).”

Vontier Corp incurred term loan of $500 million with Bank of America, N.A. at Term SOFR plus a margin of between 0.875% and 1.500%, or Base Rate plus a margin maturing February 12, 2028.

“Issuer and Swing Line Lender and Agent for a syndicate of lenders. Term Loan Facility The Term Loan Amendment amends the Existing Term Loan Agreement to consist of a three-year, $500 million senior unsecured term loan facility (the “Term Loan Facility”). Loans under the Term Loan Facility bear interest, at Vontier’s option, at the following variable per annum rates:”

AMAZE HOLDINGS, INC. incurred debt of $3,300,000 with three accredited investors at no interest unless an event of default occurs maturing November 6, 2025.

“pursuant to which the Company agreed to sell up to an aggregate principal amount of $3,300,000 of secured original issue discount notes”

Sinclair, Inc. incurred senior notes of $1,430 million with U.S. Bank Trust Company, National Association at 8.125% per annum maturing February 15, 2033.

“On February 12, 2025, STG issued $1,430 million aggregate principal amount of 8.125% First-Out First Lien Secured Notes due 2033 (the “New First-Out Notes”), which mature on February 15, 2033, pursuant to an indenture, dated as of February 12, 2025”

Applied Digital Corp. incurred term loan of $375 million with Sumitomo Mitsui Banking Corporation at Daily Simple SOFR (as defined in the Credit Agreement) plus 3.50% from the Closi maturing eighteen (18) months after the Closing Date.

“The Credit Agreement provides for an aggregate of $375 million of term loans (collectively, the “Loans”), the entire amount of which was immediately available on the Closing Date”

Workhorse Group Inc. incurred convertible notes of $35,000,000 at 9.0% per annum maturing one-year anniversary of the date hereof.

“on February 12, 2025 (the “Closing Date”), the Company issued and sold to the Investor (i) a Note in the original principal amount of $35,000,000 (the “Tenth Additional Note”)”

Texas Mineral Resources Corp. incurred convertible notes of $848,000 with thirteen accredited investors at will not bear interest maturing August 10, 2025.

“The Notes to be issued to the investors (i) will be in the aggregate principal amount of $848,000, (ii) will not bear interest, (iii) will mature and be due and payable on August 10, 2025”

Scorpius Holdings, Inc. incurred loan of $1,000,000 at 5.0% maturing April 30, 2025.

“On February 12, 2025, Scorpius Holdings, Inc., a Delaware corporation (the “Company”), issued a non-convertible promissory note (the “Note”) in the principal amount of One Million Dollars ($1,000,000) to an institutional investor (the “Holder”).”

KBS Real Estate Investment Trust III, Inc. amended credit facility of approximately $465.9 million outstanding, plus up to $15.0 million additional funding with Bank of America, N.A., as administrative agent, and the lenders listed in the filing at one-month Term SOFR plus 300 basis points maturing January 22, 2027.

“points. Prior to closing the Eighth Modification Agreement, the aggregate outstanding principal balance of the Amended and Restated Portfolio Loan Facility was approximately $465.9 million (the “Principal Debt”). The Eighth Modification Agreement provides for $15.0 million of new funding (“Additional Loan Proceeds”; the Additional Loan Proceeds together with the”

Propanc Biopharma, Inc. incurred convertible notes of $43,000 at eight percent (8%) per annum maturing October 7, 2025.

“the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $43,000”

Propanc Biopharma, Inc. incurred convertible notes of $65,000 at one-time interest charge of fifteen percent (15%) maturing November 30, 2025.

“the Investor agreed to purchase a convertible promissory note from the Company in the aggregate principal amount of $65,000”